ALPMY
Astellas Pharma Inc Unsponsored ADR (ALPMY) [ST]
▲ 2.32%
prev close
ASTELLAS PHARMA UNSP/ADR
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-02-27 | ALPMYAstellas Pharma Inc Unsponsored ADR | Buy | $15,001 - $50,000 | 1310d ago | — |
2023-02-27
Daniel Goldman
ALPMY
Amount
$15,001 - $50,000
Filed
1310d ago
Recent News
Powered by Polygon.io
Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
Monoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-02-27 · Purchase
$15,001 - $50,000